New KIT mutations in patients with piebaldism.

[1]  M. Bitner-Glindzicz,et al.  Molecular heterogeneity in two families with auditory pigmentary syndromes: the role of neuroimaging and genetic analysis in deafness , 2004, Clinical genetics.

[2]  B. K. Davis,et al.  Expansion and contraction of hypomelanotic areas in human piebaldism , 1976, Human Genetics.

[3]  B. Korf,et al.  Deletion of the SLUG (SNAI2) gene results in human piebaldism , 2003, American journal of medical genetics. Part A.

[4]  K. Devriendt,et al.  Human piebaldism: six novel mutations of the proto‐oncogene KIT , 2002, Human mutation.

[5]  A. Paller,et al.  A novel KIT mutation results in piebaldism with progressive depigmentation. , 2001, Journal of the American Academy of Dermatology.

[6]  M. Patton,et al.  Three novel mutations of the proto-oncogene KIT cause human piebaldism. , 2000, American journal of medical genetics.

[7]  I. Hatayama,et al.  A novel KIT gene missense mutation in a Japanese family with piebaldism. , 1998, The Journal of investigative dermatology.

[8]  P. Beighton,et al.  Piebaldism with deafness: molecular evidence for an expanded syndrome. , 1998, American journal of medical genetics.

[9]  T. Gallardo,et al.  Mutations in the ligand-binding domain of the kit receptor: an uncommon site in human piebaldism. , 1996, The Journal of investigative dermatology.

[10]  J. Burn,et al.  Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism. , 1995, American journal of human genetics.

[11]  P. Riva,et al.  A 12‐bp deletion ( 7818del12 ) in the c‐kit protooncogene in a large Italian kindred with piebaldism , 1995, Human mutation.

[12]  R. Spritz,et al.  A recurrent deletion in the KIT (mast/stem cell growth factor receptor) proto-oncogene is a frequent cause of human piebaldism. , 1993, Human molecular genetics.

[13]  R. Spritz,et al.  Novel mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. , 1993, The Journal of investigative dermatology.

[14]  R. Spritz.  The molecular basis of human piebaldism. , 1994, Pigment cell research.

[15]  D. Curtis,et al.  Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism. , 1992, American journal of human genetics.

[16]  R. Spritz,et al.  Deletion of the KIT and PDGFRA genes in a patient with piebaldism. , 1992, American journal of medical genetics.

[17]  R. Spritz,et al.  Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene. , 1992, Oncogene.

[18]  R. Fleischman.  Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene. , 1992, The Journal of clinical investigation.

[19]  R. Spritz,et al.  Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. , 1992, American journal of human genetics.

[20]  V. Stastny,et al.  Deletion of the c-kit protooncogene in the human developmental defect piebald trait. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Spritz,et al.  Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Ishii,et al.  Acquired pigmented macules in human piebald lesions. Ultrastructure of melanocytes in hypomelanotic skin. , 1989, Acta Dermato-Venereologica.

[23]  D. Housman,et al.  The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene , 1988, Cell.

[24]  V. Chapman,et al.  The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus , 1988, Nature.

[25]  Y. Mishima,et al.  Tyrosinase-positive melanocyte distribution and induction of pigmentation in human piebald skin. , 1988, Archives of dermatology.